Gen-Probe Submits PMA to FDA for Prostate Cancer Assay

The test, which is CE marked, is used to determine whether repeat biopsies are needed in men suspected of having prostate cancer.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories